Literature DB >> 3140898

Human skin tryptase: purification, partial characterization and comparison with human lung tryptase.

I T Harvima1, N M Schechter, R J Harvima, J E Fräki.   

Abstract

Human skin tryptase was isolated using stepwise low- and high-salt extraction and further purified 448-fold with 33% yield using octyl-Sepharose CL-4B hydrophobic affinity chromatography, Sephacryl S-200 gel filtration and finally octyl-Sepharose CL-4B or cellulose phosphate ion exchange chromatography. The skin tryptase, which has an apparent Mr of 120,000 by gel filtration in high-salt buffer, consisted of polypeptide chains of Mr 34,000 and 38,000 when resolved on SDS gels. Both polypeptide chains, labelled with [3H]diisopropyl fluorophosphate, indicated that they were representative of subunits and that the native proteinase was an aggregate of subunits. However, in some preparations only one band with Mr 34,000 was seen. In low-salt buffer the enzyme was labile and at least 1.4 M KCl was needed to keep the enzyme stabile when incubated at 37 degrees C for 30 min. Heparin glycosaminoglycan partially stabilized the tryptase but addition of protein (e.g. albumin, 80 micrograms/ml) to the tryptase-heparin mixture was needed to keep the enzyme stabile. Tryptases purified by exactly the same method from human lung tissue and from human skin had identical molecular size in gel filtration and in SDS-polyacrylamide gel electrophoresis. They also revealed identical enzyme kinetic parameters with several synthetic peptide substrates. The inhibition profile was identical for both enzymes, and they also crossreacted completely in immunodiffusion plates. These studies strongly indicate that mast cells found in skin as well as lung contain closely related, possible identical trypsin-like proteinases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3140898     DOI: 10.1016/0167-4838(88)90158-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

1.  Cloning and characterization of a second complementary DNA for human tryptase.

Authors:  J S Miller; G Moxley; L B Schwartz
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

2.  Stem cell factor-dependent human cord blood derived mast cells express alpha- and beta-tryptase, heparin and chondroitin sulphate.

Authors:  G Nilsson; T Blom; I Harvima; M Kusche-Gullberg; K Nilsson; L Hellman
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

3.  Mast cell tryptases: examination of unusual characteristics by multiple sequence alignment and molecular modeling.

Authors:  D A Johnson; G J Barton
Journal:  Protein Sci       Date:  1992-03       Impact factor: 6.725

Review 4.  Proteolysis and Oxidation of Therapeutic Proteins After Intradermal or Subcutaneous Administration.

Authors:  Ninad Varkhede; Rupesh Bommana; Christian Schöneich; M Laird Forrest
Journal:  J Pharm Sci       Date:  2019-08-10       Impact factor: 3.534

5.  Isolation and characterization of trypsin-like and chymotrypsin-like proteinases from human cholesteatoma.

Authors:  K Hochstrasser; G J Albrecht; W Gebhard; G Rasp; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

6.  Biochemical and histochemical evaluation of tryptase in various human tissues.

Authors:  I T Harvima; K Karkola; R J Harvima; A Naukkarinen; H Neittaanmäki; M Horsmanheimo; J E Fräki
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

7.  Nerve growth factor-beta induces mast-cell marker expression during in vitro culture of human umbilical cord blood cells.

Authors:  P Welker; J Grabbe; B Gibbs; T Zuberbier; B M Henz
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

8.  Interaction of human mast cell tryptase and chymase with low-molecular-mass serine proteinase inhibitors from the human respiratory tract.

Authors:  K Hochstrasser; W Gebhard; G Albrecht; G Rasp; E Kastenbauer
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

9.  Mast cell tryptase and chymase in developing and mature psoriatic lesions.

Authors:  I T Harvima; A Naukkarinen; K Paukkonen; R J Harvima; M L Aalto; L B Schwartz; M Horsmanheimo
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

10.  Separation and partial characterization of proteinases with substrate specificity for basic amino acids from human MOLT-4 T lymphocytes: identification of those inhibited by variable-loop-V3 peptides of HIV-1 (human immunodeficiency virus-1) envelope glycoprotein.

Authors:  I T Harvima; R J Harvima; G Nilsson; L Ivanoff; L B Schwartz
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.